↓ Skip to main content

An Oral Galectin Inhibitor in COVID-19—A Phase II Randomized Controlled Trial

Overview of attention for article published in Vaccines, March 2023
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#32 of 4,581)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
35 news outlets
twitter
979 X users
reddit
2 Redditors

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
12 Mendeley